ZYME - Zymeworks Inc.

QQQ $ 440.32 $ 0.07 (0.02 %)

DIA $ 388.70 $ 0.29 (0.07 %)

SPY $ 517.26 $ 0.57 (0.11 %)

TLT $ 90.79 $ 0.55 (0.61 %)

GLD $ 214.23 $ -0.99 (-0.46 %)

Previous Close

$ 9.12

Open

$ 8.90

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 8.84 - $ 9.41

52 Week Range

$ 6.02 - $ 13.14

Volume

595,138

Average Volume

Market Cap

574.53M

Beta (5Y Monthly)

$ 0.98

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	03-06-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	03-07-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Zymeworks Stock: A Deep Dive Into Analyst ...
05/07/2024 13:00:42

HC Wainwright & Co. Reiterates Neutral on ...
05/07/2024 10:21:13

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.

Citigroup Maintains Buy on Zymeworks, Lowe...
05/03/2024 21:57:07

Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and lowers the price target from $17 to $16.

Wells Fargo Maintains Overweight on Zymewo...
05/03/2024 18:04:42

Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Overweight and lowers the price target from $14 t...

Zymeworks Q1 2024 GAAP EPS $(0.42) Misses ...
05/02/2024 20:27:21

Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by ...

Zymeworks Presents New Data from Multiple ...
04/08/2024 10:05:55

Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional bi...

Wells Fargo Maintains Overweight on Zymewo...
03/12/2024 11:17:18

Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Overweight and raises the price target from $12 t...

HC Wainwright & Co. Maintains Neutral on Z...
03/11/2024 10:41:44

HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Neutral and raises the price target fr...

Zymeworks Q4 Adj EPS $(0.16) Beats $(0.43)...
03/06/2024 21:12:13

Zymeworks (NASDAQ:ZYME) reported quarterly Adj losses of $(0.16) per share which beat the analyst consensus estimate of $(0.43)...

Earnings Scheduled For March 6, 2024
03/06/2024 10:00:02

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

Zymeworks To Present Preclinical Data On A...
03/05/2024 21:35:03

Five abstracts accepted for poster presentation highlight company's differentiated antibody-drug conjugate and multispecifi...

A Look Into Healthcare Sector Value Stocks
01/22/2024 14:44:12

overview-of-value-stocks-in-the-healthcare-sector

Overview Of Value Stocks In The Healthcare...
01/15/2024 14:42:57

Zymeworks Says Cash, Cash Equivalents, And...
01/04/2024 11:17:26

Zymeworks Entered Into A Securities Purcha...
12/26/2023 13:03:32

5 Value Stocks In The Healthcare Sector
12/04/2023 14:44:10

Recap: Zymeworks Q3 Earnings
11/07/2023 21:40:50

Zymeworks Q3 EPS $(0.41) Beats $(0.47) Est...
11/07/2023 21:18:32

Zymeworks (NASDAQ:ZYME) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.47) by ...

Earnings Scheduled For November 7, 2023
11/07/2023 11:34:30

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

LEO Pharma Terminated License Agreement Wi...
11/02/2023 20:36:59

-8-K